It has also been pointed out a modifying effect of IGF-I polymorphisms on the genetic risk of AD [190], whereas the ApoE4 genotype modulates brain responses to insulin [191], whose effects are related to IGF-I. This evidence concerns the gene IGF1 and Alzheimer disease.